June Sherie Almenoff, Director at NeuBase Therapeutics, holds 1.99K shares in Tenax Therapeutics (Ticker: TENX), holds 4.17K shares in Avalo Therapeutics (Ticker: AVTX), holds 13.18K shares in Brainstorm Cell Therapeutics (Ticker: BCLI). Most recently, June Sherie Almenoff Bought ― shares of Tenax Therapeutics on Nov 19, 2025 for an estimated value of $14.93K.
What was June Sherie Almenoff’s latest transaction?
June Sherie Almenoff latest transaction was an Informative Buy of $14.93K.
What was June Sherie Almenoff's most profitable transaction?
June Sherie Almenoff’s most profitable transaction was an Informative Buy of TENX stock on November 19, 2025. The return on the trade was 41.60%.
What is June Sherie Almenoff's role in NeuBase Therapeutics?
June Sherie Almenoff's role in NeuBase Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.